Genetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular disease

Cited by (259)

Items 101–200 of 259

1. Association of very Low-density Lipoprotein Cholesterol with All-cause and Cardiovascular Mortality in Peritoneal Dialysis
   Xishao Xie, Xiaohui Zhang, Shilong Xiang, Xingqun Yan, Haojie Huang, Yuanshi Tian, Zhangfei Shou, Jianghua Chen · 2017 · Kidney & Blood Pressure Research
2. Association of remnant cholesterol with risk of dementia: a nationwide population-based cohort study in South Korea
   Ji Hye Heo, Han Na Jung, Eun Roh, Kyungdo Han, Jun Goo Kang, Seong Jin Lee, Sung‐Hee Ihm · 2024 · The Lancet Healthy Longevity
3. Association between RC/HDL-C ratio and risk of non-alcoholic fatty liver disease in the United States
   Yanyan Xuan, Weike Hu, Yudan Wang, Jingwen Li, Lisha Yang, Songping Yu, Dongdong Zhou · 2024 · Frontiers in Medicine
4. Association between triglyceride and depression: A systematic review and meta-analysis
   Di-Ru Xu, Xi Gao, Libo Zhao, Shudong Liu, Ge Tang, Chanjuan Zhou, Yu Chen · 2024 · PLoS ONE
5. Electronegative Low-density Lipoprotein Increases Coronary Artery Disease Risk in Uremia Patients on Maintenance Hemodialysis
   Chiz‐Tzung Chang, Guei‐Jane Wang, Chin‐Chi Kuo, Ju-Yi Hsieh, An-Sean Lee, Chia‐Ming Chang, Chun‐Cheng Wang, Ming‐Yi Shen, Chiu‐Ching Huang, Tatsuya Sawamura et al. · 2016 · Medicine
6. Adiposity and Genetic Factors in Relation to Triglycerides and Triglyceride-Rich Lipoproteins in the Women's Genome Health Study
   Shafqat Ahmad, Samia Mora, Paul W. Franks, Marju Orho‐Melander, Paul M. Ridker, Frank B. Hu, Daniel I. Chasman · 2017 · Clinical Chemistry
7. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at “Extreme” ASCVD Risk
   Paul D. Rosenblit · 2019 · Current Diabetes Reports
8. Experimental therapies targeting apolipoprotein C-III for the treatment of hyperlipidemia – spotlight on volanesorsen
   Dimitrios Milonas, Κωνσταντίνος Τζιόμαλος · 2019 · Expert Opinion on Investigational Drugs
9. Lipid metabolism contribute to the pathogenesis of IgA Vasculitis
   Ying Liu, Min Wen, Qingnan He, Xiqiang Dang, Shipin Feng, Taohua Liu, Xuewei Ding, Xiaoyan Li, Xiaojie He · 2022 · Diagnostic Pathology
10. Colesterol remanente, riesgo vascular y prevención de la arteriosclerosis
    Xavier Pintó, Marta Fanlo‐Maresma, Virginia Esteve, Jesús Millán, Agustín Blanco, Mariano Blasco, José Luis Díaz-Díaz, Ángel Díaz Rodríguez, Alipio Mangas, Vicente Pascual et al. · 2023 · Clínica e Investigación en Arteriosclerosis
11. Relationship between remnant cholesterol and risk of heart failure in participants with diabetes mellitus
    Ruoting Wang, Hertzel C. Gerstein, Harriette G.C. Van Spall, Gregory Y.H. Lip, Iván Olier, Sandra Ortega‐Martorell, Lehana Thabane, Zebing Ye, Guowei Li · 2023 · European Heart Journal - Quality of Care and Clinical Outcomes
12. Lipidomic signature of serum from the rats exposed to alcohol for one year
    Hongchun Li, Wei Xu, Linhong Jiang, Hui Gu, Menglu Li, Jiamei Zhang, Wei Guo, Pengchi Deng, Hailei Long, Qian Bu et al. · 2018 · Toxicology Letters
13. Prevalence of metabolic syndrome and its components in women with and without pelvic organ prolapse and its association with prolapse severity according to the Pelvic Organ Prolapse Quantification system
    Giulia Gava, Stefania Alvisi, Ilaria Mancini, Renato Seracchioli, Maria Cristina Meriggiola · 2018 · International Urogynecology Journal
14. Erythrocyte Membrane Polyunsaturated Fatty Acids Are Associated with Incidence of Metabolic Syndrome in Middle-Aged and Elderly People–An 8.8-Year Prospective Study
    Ding Ding, Yihong Li, Mianli Xiao, Hongli Dong, Jie-sheng Lin, Gengdong Chen, Zhan-yong Chen, Xinyi Tang, Yu‐Ming Chen · 2020 · Journal of Nutrition
15. Genetics of Triglyceride-Rich Lipoproteins Guide Identification of Pharmacotherapy for Cardiovascular Risk Reduction
    Aleesha Shaik, Robert S. Rosenson · 2021 · Cardiovascular Drugs and Therapy
16. Association between miR-146a and Tumor Necrosis Factor Alpha (TNF-α) in Stable Coronary Artery Disease
    Tiago Pereira‐da‐Silva, Patrícia Napoleão, Marina C. Costa, André F. Gabriel, Mafalda Selas, Filipa Silva, Francisco J. Enguita, Rui Cruz Ferreira, Miguel Mota Carmo · 2021 · Medicina
17. Biomarker Discovery in Atherosclerotic Diseases Using Quantitative Nuclear Magnetic Resonance Metabolomics
    Shuai Ma, Mingfeng Xia, Xin Gao · 2021 · Frontiers in Cardiovascular Medicine
18. Association of elevated triglycerides and acute myocardial infarction in young Hispanics
    Gilbert Essilfie, David M. Shavelle, Han Tun, Kevin D. Platt, Ryan Kobayashi, Anilkumar Mehra, Ray V. Matthews, Leonardo Clavijo, Michael Angelo Gaglia · 2016 · Cardiovascular revascularization medicine
19. Inhibition of perilipin 2 expression reduces pro-inflammatory gene expression and increases lipid droplet size
    Jennifer Norman, Hnin Hnin Aung, Dennis W. Wilson, John C. Rutledge · 2018 · Food & Function
20. Optimal Medical Therapy Targeting Lipids and Inflammation for Secondary Prevention in Patients Undergoing Percutaneous Coronary Intervention
    Imma Forzano, Domenico Florimonte, Viviana Narciso, Mario Enrico Canonico, Domenico Simone Castiello, Lina Manzi, Stefano Cristiano, Alessandra Maria Spinelli, Donato Maria Vallone, Dario D’Alconzo et al. · 2025 · Journal of Clinical Medicine
21. The effects of phytochemicals on serum triglycerides in subjects with hypertriglyceridemia: A systematic review of randomized controlled trials
    Sahar Dadkhah Tehrani, Mehrnaz Shojaei, Mohammad Bagherniya, Matteo Pirro, Amirhossein Sahebkar · 2023 · Phytotherapy Research
22. The year in cardiology 2015: prevention
    M. John Chapman, Stefan Blankenberg, Ulf Landmesser · 2016 · European Heart Journal
23. Riesgo cardiovascular residual de origen lipídico. Componentes y aspectos fisiopatológicos
    Antonio Hernández‐Mijares, Juan Francisco Ascaso, Mariano Blasco, Ángel Brea, Ángel Díaz Rodríguez, Teresa Mantilla, Juan Pedro‐Botet, Xavier Pintó, Jesús Millán · 2018 · Clínica e Investigación en Arteriosclerosis
24. Current and Emerging Therapies for Atherosclerotic Cardiovascular Disease Risk Reduction in Hypertriglyceridemia
    Reed Mszar, Sarah Bart, Alexander P. Sakers, Daniel E. Soffer, Dean G. Karalis · 2023 · Journal of Clinical Medicine
25. Inhibition of Angiopoietin-Like Protein 3 or 3/8 Complex and ApoC-III in Severe Hypertriglyceridemia
    Miriam Larouche, Étienne Khoury, Diane Brisson, Daniel Gaudet · 2023 · Current Atherosclerosis Reports
26. Hyperlipidemias and Obesity
    Marc Thiriet · 2018 · Biomathematical and biomechanical modeling of the circulatory and ventilatory systems
27. Mendelian Randomization Analyses for Selection of Therapeutic Targets for Cardiovascular Disease Prevention: a Note of Circumspection
    Robert S. Rosenson, Wolfgang Köenig · 2016 · Cardiovascular Drugs and Therapy
28. Comprehensive (apo)lipoprotein profiling in patients with genetic hypertriglyceridemia using LC-MS and NMR spectroscopy
    Maaike E. Straat, Borja Martínez‐Téllez, Kimberly J. Nahon, Laura G.M. Janssen, Aswin Verhoeven, Leonie van der Zee, Monique T Mulder, Sander Kooijman, Mariëtte R. Boon, Jeanine E. Roeters van Lennep et al. · 2022 · Journal of clinical lipidology
29. Triglycerides Revisited to the Serial
    Paulo Ricardo Nazário Viecili, Brenda da Silva, Gabriela Elisa Hirsch, Fernando Garcez Porto, Mariana Migliorini Parisi, Alison R. Castanho, Michele Wender, Jonatas Zeni Klafke · 2017 · Advances in clinical chemistry
30. Calculated Non-HDL Cholesterol Includes Cholesterol in Larger Triglyceride-Rich Lipoproteins in Hypertriglyceridemia
    Cathy Sun, Christopher R. McCudden, Diane Brisson, Julie L. V. Shaw, Daniel Gaudet, Teik Chye Ooi · 2019 · Journal of the Endocrine Society
31. Association between fasting Triglyceride levels and the Prevalence of Asymptomatic Intracranial Arterial Stenosis in a Chinese Community-based Study
    Jianwei Wu, Yu Wang, Anxin Wang, Jian Xie, Xingquan Zhao · 2018 · Scientific Reports
32. Varinostat Alters Gene Expression Profiles in Aortic Tissues from ApoE −/– Mice
    Yicong Ye, Xiliang Zhao, Yi-yun Lu, Bo Long, Shuyang Zhang · 2018 · Human Gene Therapy Clinical Development
33. Triglycerides as Residual Risk for Atherosclerotic Cardiovascular Disease
    Hirotoshi Ohmura · 2019 · Circulation Journal
34. A significant presence in atherosclerotic cardiovascular disease: Remnant cholesterol: A review
    Li Wang, Qingmei Zhang, Zhiyang Wu, Xiwei Huang · 2024 · Medicine
35. Remnant cholesterol, vascular risk, and prevention of atherosclerosis
    Xavier Pintó, Marta Fanlo‐Maresma, Virginia Esteve-Luque, Jesús Millán · 2023 · Clínica e Investigación en Arteriosclerosis (English Edition)
36. Electronegative low-density lipoprotein increases the risk of ischemic lower-extremity peripheral artery disease in uremia patients on maintenance hemodialysis
    Chiz‐Tzung Chang, Ming‐Yi Shen, An-Sean Lee, Chun‐Cheng Wang, Wei‐Yu Chen, Chia‐Ming Chang, Kuan‐Cheng Chang, Nicole Stancel, Chu‐Huang Chen · 2017 · Scientific Reports
37. Discordance between remnant cholesterol and low-density lipoprotein cholesterol predicts arterial stiffness progression
    Shouling Wu, Xin Su, Yingting Zuo, Shuohua Chen, Xue Tian, Qin Xu, Yijun Zhang, Xiaoli Zhang, Penglian Wang, Yan Ling He et al. · 2023 · Hellenic Journal of Cardiology
38. A Gene Variation at the ZPR1 Locus (rs964184) Interacts With the Type of Diet to Modulate Postprandial Triglycerides in Patients With Coronary Artery Disease: From the Coronary Diet Intervention With Olive Oil and Cardiovascular Prevention Study
    Juan Francisco Alcala-Diaz, Antonio P. Arenas-de Larriva, José David Torres-Peña, Fernando Rodríguez-Cantalejo, Oriol Alberto Rangel-Zúñiga, Elena M. Yubero‐Serrano, Francisco Miguel Gutierrez-Mariscal, Magdalena P. Cardelo, Raul Miguel Luque, José María Ordovás et al. · 2022 · Frontiers in Nutrition
39. Plasma lipids in patients with inflammatory bowel disease
    Şeref Kul, Zuhal Çalışkan, Tolga Sinan Güvenç, Rengin Çetin Güvenç, Mustafa Çalışkan · 2020 · Wiener klinische Wochenschrift
40. New Challenges for HDL-Modifying Therapies as a Strategy to Lower Cardiovascular Disease Events in Statin-Treated Patients
    Robert S. Rosenson, H. Bryan Brewer · 2015 · Cardiovascular Drugs and Therapy
41. Association of remnant cholesterol with depression, type 2 diabetes, and their coexistence
    Yafei Mao, Rui Zhao, Xinyuan Li, Yulan Geng · 2025 · BMC Psychiatry
42. Metabolic Overlap between Alzheimer’s Disease and Metabolic Syndrome Identifies the PVRL2 Gene as a New Modulator of Diabetic Dyslipidemia
    Montse Guardiola, Gerard Muntané, Iris Martínez, Lourdes Martorell, Josefa Girona, Daiana Ibarretxe, Núria Plana, Maria Jesus Bullido, Elisabet Vilella, Josep Ribalta · 2023 · International Journal of Molecular Sciences
43. Connecting impaired fibrinolysis and dyslipidemia
    Maya Rodriguez, Ze Zheng · 2024 · Research and Practice in Thrombosis and Haemostasis
44. Reversal of severe hypertriglyceridemia with intermittent fasting and a very-low-carbohydrate ketogenic diet: a case series
    Subrat Das, Jordan McCreary, Shariq Shamim, Tro Kalayjian · 2020 · Current Opinion in Endocrinology Diabetes and Obesity
45. Cholesteryl Ester Transfer Protein Impairs Triglyceride Clearance via Androgen Receptor in Male Mice
    Brian T. Palmisano, Uche Anozie, Sophia Yu, Joshua Charles Neuman, Lin Zhu, Emery M. Edington, Thao N. Luu, John M. Stafford · 2020 · Lipids
46. Ethnic differences in ApoC-III concentration and the risk of cardiovascular disease: No evidence for the cardioprotective role of rare/loss of function APOC3 variants in non-Europeans
    Madhusmita Rout, Megan R. Lerner, Piers R. Blackett, Marvin D. Peyton, Stavros Stavrakis, Evgeny V. Sidorov, Dharambir K. Sanghera · 2022 · American Heart Journal Plus Cardiology Research and Practice
47. Cynanchum wilfordii Etanolic Extract Controls Blood Cholesterol: A Double-blind, Randomized, Placebo-Controlled, Parallel Trial
    Ji Sun Youn, Young‐Min Ham, Weon‐Jong Yoon, Ho-Chun Choi, Ji Eun Lee, Belong Cho, Ji Yeon Kim · 2019 · Nutrients
48. Relative effect of hypertriglyceridemia on non-HDLC and apolipoprotein B as cardiovascular disease risk markers
    Cathy Sun, Diane Brisson, Daniel Gaudet, Teik Chye Ooi · 2020 · Journal of clinical lipidology
49. Two‐Year Changes in Remnant Cholesterol and Stroke Risk in the Chinese Population: A Prospective Cohort Study
    Dan Wang, Zifei Zhang, Yijun Zhang, Shuohua Chen, Nan Qu, Haibin Li, Yongkang Sun, Xue Tian, Xinsheng Han, Shouling Wu et al. · 2025 · Journal of the American Heart Association
50. Extracellular Vesicles From Chylomicron-Treated Endothelial Cells Drive Macrophage Inflammation
    Anna Tilp, Dimitris Nasias, Andrew Carley, Min Young Park, Ashley Mooring, Munichandra Babu Tirumalasetty, Nada A. Abumrad, Yang Wang, Qing Miao, E. Douglas Lewandowski et al. · 2025 · Arteriosclerosis Thrombosis and Vascular Biology
51. Nonfasting Triglyceride as an Independent Predictor of Carotid Restenosis After Carotid Endarterectomy or Carotid Artery Stenting
    Yoichi Miura, Hideki Kanamaru, Ryuta Yasuda, Naoki Toma, Hidenori Suzuki · 2021 · World Neurosurgery
52. Managing of dyslipidaemia characterized by accumulation of triglyceride-rich lipoproteins
    Visser, Jolien, van Zwol, Willemien, Kuivenhoven, Jan Albert · 2022 · Current Atherosclerosis Reports
53. Non-Fasting Hypertriglyceridemia Burden as a Residual Risk of the Progression of Carotid Artery Stenosis
    Yoichi Miura, Ryuta Yasuda, Naoki Toma, Hidenori Suzuki · 2022 · International Journal of Molecular Sciences
54. Prognostic value of remnant cholesterol in patients with coronary heart disease: A systematic review and meta-analysis of cohort studies
    Yun Tian, Wenli Wu, Qin Li, Xiuqiong Yu, Lin Cai, Han Wang, Zhen Zhang · 2023 · Frontiers in Cardiovascular Medicine
55. Non-Fasting Hypertriglyceridemia as an Independent Risk Factor for Coronary In-Stent Restenosis after Primary Bare Metal Stent Implantation in Patients with Coronary Artery Disease
    Masayuki Yoshimura, Seiji Umemoto, Reo Kawano, Mitsuyuki Hiromoto, Michio Yamada, Tatsuhiro Fujimura, Masakazu Tanaka, Tomoko Nao, Toshiro Miura, Masafumi Yano · 2021 · International Heart Journal
56. Plasma lipid alterations in young adults with psychotic experiences: A study from the Avon Longitudinal Study of Parents and Children cohort
    Xiaofei Yin, David Mongan, Mary D Cannon, Stanley Zammit, Tuulia Hyötyläinen, Matej Orešič, Lorraine Brennan, David Cotter · 2022 · Schizophrenia Research
57. Bee bread attenuates the progression of atherosclerosis by activating Nrf2/Keap1 and modulating TNF-α/NF-κβ-associated mast cell migration and a mitochondrial-dependent apoptotic pathway in the obese rat model
    Zaidatul Akmal Othman, Zaida Zakaria, Joseph Bagi Suleiman, Nur Asyilla Che Jalil, Wan Syaheedah Wan Ghazali, Mahaneem Mohamed · 2022 · Food & Function
58. Colesterol-no HDL como objetivo terapéutico
    Ángel Brea, Antonio Hernández‐Mijares, Jesús Millán, Juan Francisco Ascaso, Mariano Blasco, Ángel Díaz Rodríguez, Teresa Mantilla, Juan Pedro‐Botet, Xavier Pintó · 2019 · Clínica e Investigación en Arteriosclerosis
59. Changes in triglyceride-rich lipoprotein particle profiles in response to one-week on a low fat or Mediterranean diet by TCF7L2 rs7903146 genotype: a randomized crossover dietary intervention trial
    Chao‐Qiang Lai, Julie E Gervis, Laurence D. Parnell, Alice Hinda Lichtenstein, José María Ordovás · 2025 · Genes & Nutrition
60. Anterior Circulation Acute Ischemic Stroke in the Plateau of China: Risk Factors and Clinical Characteristics
    Yujia Yan, Xiqiang Zhang, Hecheng Ren, Xingwei An, Wanpeng Fan, Jingbo Liang, Ying Huang · 2022 · Frontiers in Neurology
61. A novel regulatory facet for hypertriglyceridemia: The role of microRNAs in the regulation of triglyceride-rich lipoprotein biosynthesis
    Masoumeh Khalifeh, Raul Dias Santos, Reza Kazemi Oskuee, Ali Badiee, Seyed Hamid Aghaee‐Bakhtiari, Amirhossein Sahebkar · 2022 · Progress in Lipid Research
62. Omega-3 fatty acid therapy for cardiovascular disease: justified or not?
    Kevin Carl Maki, Mary R. Dicklin · 2020 · Current Opinion in Cardiology
63. Personalized Nutrition Biomarkers and Dietary Strategies for Atherosclerosis Risk Management: A Systematic Review
    Khadijah Fayyaz, Muhammad Saeeduddin, Husnain Bashir, Firdos Ahmad, Colin James Barrow, Nauman Khalid · 2025 · Nutrients
64. Non-remnant triglyceride-rich lipoproteins due to lipoprotein lipase deficiency increase atherosclerosis in mice
    Ainara G. Cabodevilla, María Concepción Izquierdo, Debapriya Basu, Waqas Younis, Munichandra Babu Tirumalasetty, Qing Robert Miao, Dimitris Nasias, Jenny E. Kanter, Tse Wing Winnie Ho, Jana Gjini et al. · 2026 · Nature Communications
65. Remnant cholesterol predicts the development of type 2 diabetes in patients with nonalcoholic fatty liver disease
    Liping Yang, Hangkai Huang, Zejun Wang, Chengfu Xu · 2025 · Diabetology & Metabolic Syndrome
66. The Novelty of Icosapent Ethyl in the Management of Hypertriglyceridemia and Alleviating Cardiovascular Risk
    Muhammad Shoaib Khan, Muhammad Ishaq, Muhammad Talha Ayub, Ateeq U. Rehman, John J. Hayes, M. Eyman Mortada, Robert W Biederman · 2021 · Journal of Lipids
67. Phospholipid transfer to high-density lipoprotein (HDL) upon triglyceride lipolysis is directly correlated with HDL-cholesterol levels and is not associated with cardiovascular risk
    Feng Ma, Maryam Darabi, Marie Lhomme, Emilie Tubeuf, Aurélie Canicio, Jean Brerault, Narcisse Medadje, Fabiana Hanna Rached, Sandrine Lebreton, Éric Frisdal et al. · 2021 · Atherosclerosis
68. Positive Association between Triglyceride-Rich Lipoprotein Cholesterol and Diabetes Mellitus in Hypertensive Patients
    Wei Zhou, Yu Yu, Lingjuan Zhu, Wangsheng Fang, Tao Yu, Minghui Li, Xiao Bo Huang, Tao Wang, Huihui Bao, Xiaoshu Cheng · 2021 · International Journal of Endocrinology
69. A lipidologist perspective of global lipid guidelines and recommendations, part 1: Lipid treatment targets and risk assessment
    Harold Edward Bays · 2015 · Journal of clinical lipidology
70. Hepatocyte Small Heterodimer Partner Mediates Sex-Specific Effects on Triglyceride Metabolism via Androgen Receptor in Male Mice
    Brian T. Palmisano, Lin Zhu, Bridget Litts, Andreanna Burman, Sophia Yu, Joshua Charles Neuman, Uche Anozie, Thao N. Luu, Emery M. Edington, John M. Stafford · 2021 · Metabolites
71. Multitrait genetic-phenotype associations to connect disease variants and biological mechanisms
    Hanna Julienne, Vincent Laville, Zachary Ryan McCaw, Zihuai He, Vincent Guillemot, Carla Lasry, Andrey Ziyatdinov, Amaury Vaysse, Pierre Lechat, Hervé Ménager et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
72. Schwere Hypertriglyzeridämie
    Ursula Kassner, Michaela Dippel, Elisabeth Steinhagen‐Thiessen · 2017 · Der Internist
73. Elevated remnant cholesterol and the risk of prevalent major depressive disorder: a nationwide population-based study
    Shiyi Tao, Lintong Yu, Jun Li, Ji Wu, Deshuang Yang, Xuanchun Huang, Tiantian Xue · 2024 · Frontiers in Psychiatry
74. Insights Into Causal Effects of Genetically Proxied Lipids and Lipid‐Modifying Drug Targets on Cardiometabolic Diseases
    Liwan Fu, Qin Liu, Hong Cheng, Xiaoyuan Zhao, Jingfan Xiong, Jie Mi · 2025 · Journal of the American Heart Association
75. Treatment With Evinacumab Links a New Pathogenic Variant in the LPL Gene to Persistent Chylomicronemia
    Miriam Larouche, Poulabi Banerjee, Diane Brisson, Robert C. Pordy, Daniel Gaudet · 2025 · Journal of the Endocrine Society
76. Platelets inhibit development of atherosclerosis in atherosclerotic mice
    Xiaowei Liu, Yizhong Bao, Lin Zhang, Lijiang Tang, Ping Mao · 2022 · Cell Cycle
77. Circulating vitamin E and cardiometabolic measures: a Mendelian randomization analysis
    Chuanlong Fan, Tao Huang, Xuejun Kong, Xiaohong Zhang, Zuquan Zou, Jing Xiao · 2019 · Journal of Clinical Biochemistry and Nutrition
78. Cerebrovascular pathology and metabolic syndrome
    M. М. Tanashyan · 2019
79. Severe Hypertriglyceridemia as a Cause of Aortic Thrombus with Peripheral Embolic Complications
    Maya S. Safarova, Kamal Gupta · 2022 · Kansas Journal of Medicine
80. Hypertriglyceridemia – a new and important present
    Цыганкова Оксана Васильевна, N. E. Apartseva, Ametov As · 2023 · Endocrinology News Opinions Training
81. Nuevos tratamientos en la hipertrigliceridemia y en la hiperquilomicronemia
    Juan de Dios García-Díaz · 2020 · Medicina Clínica
82. Association of Antituberculosis Treatment and Lower Risk of Hyperlipidemia in Taiwanese Patients: A Population-Based Case–Control Study
    Ying‐Ray Lee, Ni Tien, Cheng‐Li Lin, Hsin-Yi Shen, Da‐Tian Bau, Yun-Ping Lim · 2018 · In Vivo
83. Genome-Wide Analysis of Nuclear Magnetic Resonance Metabolites Revealed Parent-of-Origin Effect on Triglycerides in Medium Very Low-Density Lipoprotein in PTPRD Gene
    Natalia Pervjakova, Viktorija Kukushkina, Toomas Haller, Silva Kasela, Anni Joensuu, Kati Kristiansson, Tarmo Annilo, Markus Perola, Veikko V Salomaa, Pekka Jousilahti et al. · 2018 · Biomarkers in Medicine
84. Prevalence Rate and Correlation Between Triglyceride Level and Human Body Mass Index in Sulaimani Province, Iraq
    Sakar Ahmed, Ary Bahman Faiq, Abdullah Ahmed Hama, Asmar Hama Salih · 2021 · Iraqi Journal of Science
85. Triglyceride-rich Lipoprotein Cholesterol (Remnant Cholesterol) as a Therapeutic Target for Cardiovascular Disease Risk
    Børge Grønne Nordestgaard, Anette Varbo · 2020 · Contemporary cardiology
86. Association between remnant cholesterol and depression in middle-aged and older Chinese adults: a population-based cohort study
    Yang Zhou, Yan Lin, Yanhui Yang, Lei Wang, Juan Xu, Yuanzeng Zhu · 2025 · Frontiers in Endocrinology
87. Hipertrigliceridemia (> 150 mg/dl) como marcador de riesgo cardiovascular
    José López-Miranda · 2025 · Clínica e Investigación en Arteriosclerosis
88. Cumulative remnant cholesterol and major adverse cardiovascular events among adults with type 2 diabetes
    Yu-Wen Qian, Zhong‐Yue Liu, Fei Fang, Jiamin Wang, Xiao-Ping Shao, Yiping Jia, Xiaojing Wu, Fu‐Rong Li, Wei Zhang, Huanhuan Yang et al. · 2025 · American Journal of Preventive Cardiology
89. Unraveling novel pancreatic lipase and cholesterol esterase inhibitory peptides in Oryza Sativa L. and their mechanism by peptidomics, molecular dynamics simulations, and cell study
    Liuyi Wei, Taoying Wu, Hao Wu, Li Wen, Bo Cui, Yunhui Cheng · 2026 · Food Bioscience
90. Exogenous dietary factors as important modulator of human lipid profile
    Lilla Pawlik-Sobecka, Sylwia Płaczkowska, Anna Rorbach-Dolata, Agnieszka Piwowar · 2019 · Journal of Pre-Clinical and Clinical Research
91. Prevalence and predictive role of hypertriglyceridemia in statin-treated patients at very high risk: Insights from the START study
    Leonardo De Luca, Pier Luigi Temporelli, Michele Massimo Gulizia, Lucio Gonzini, T Ammaturo, Luigi Tedesco, Silvia Pede, Fabrizio Giovanni Oliva, Domenico Gabrielli, Furio Colivicchi et al. · 2023 · Nutrition Metabolism and Cardiovascular Diseases
92. Lower extremity arterial plaque in patients with type 2 diabetes mellitus: A cross-sectional study of 25-(OH)D3 and other risk factors
    Xuechun Hang, Xiaohua Yu, Shengyu Fan · 2023 · Journal of Diabetes and its Complications
93. Management of lipid abnormalities in metabolic syndrome
    Maria Mohammed Fariduddin, Ramachandra G. Naik · 2024 · Elsevier eBooks
94. Association between remnant cholesterol and culprit vessel physiological features in patients with acute coronary syndrome: An optical coherence tomography study
    Shitao Luo, Shuangya Yang, Pan Li, Ning Gu, Deguang Yang, Zhibing Lu, Zaili Lu, Ranzun Zhao, Bei Shi · 2025 · Journal of clinical lipidology
95. The year in cardiology 2015: prevention.
    M. John Chapman, Stefan Blankenberg, Ulf Landmesser · 2016 · Cardiologia Croatica
96. Pediatric dyslipidemias: lipoprotein metabolism disorders in children
    Rami A. Ballout, Alan Thomas Remaley · 2021 · Elsevier eBooks
97. Effects of Eicosapentaenoic Acid Plus Docosapentaenoic Acid and Eicosapentaenoic Acid Alone on Fasting and Postprandial Lipids
    Kevin Carl Maki, William F. Keane, George Bobotas, Huaizhu Wu, Christie Mitchell Ballantyne · 2016 · Journal of clinical lipidology
98. Changing Recommendations on the Use of Non-Fasting Versus a Fasting Lipid Profile: A Review of Current Literature
    Kaumudi Bery, Muhamad Ali Alherk, Mohammad Ammar Mohamad Kais Yahia, Kiran Govindankutty · 2022 · Scholars Journal of Applied Medical Sciences
99. Association Between Remnant Cholesterol and Nonalcoholic Fatty Liver Disease: A Systemic Review and Meta-Analysis
    Jiake Tang, Ting Tang, Qingwen Yu, Xuhan Tong, Chun Liu, Chen Chen, Siqi Hu, Shenghui Zhang, Yao You, Chunyi Wang et al. · 2024 · Metabolic Syndrome and Related Disorders
100. Hypertriglyceridemia (> 150 mg/dL) as a marker of cardiovascular risk
     José López-Miranda · 2025 · Clínica e Investigación en Arteriosclerosis (English Edition)